Skip to main content
ENTX logo

ENTX · Entera Bio Ltd. · Holdings

Track ENTX — free
$3.05 +0.03 (+0.99%) At close · Oct 21
Market Cap
$528.08M
Shares
173.14M
Volume · Oct 21 784.6K Avg daily vol (3M) 1.89M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 27
Total Value: $19,061,941
Total Shares: 10,738,983

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 27 13F filers
Top Holder
54.8%
Sep 2023 → Jun 2026 · range 54.8% – 95.9%
of institutional value
Top 5
90.2%
Sep 2023 → Jun 2026 · range 90.1% – 99.2%
of institutional value
Top 10
96.4%
Sep 2023 → Jun 2026 · range 96.4% – 100.0%
of institutional value
HHI
3,587
Sep 2023 → Jun 2026 · range 3,587 – 9,204
Highly concentrated

Who Holds ENTX

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 27 filers, like-for-like change +36.3%; actively managed books +38.9%; index-like books -81.9%.

Holder type Share Filers Change
Registered adviser 10.3% 9 -21.4%
Exempt adviser 0.2% 2 -88.7%
Bank 3.0% 3 +82.3%
Broker-dealer 0.0% 1 0.0%
Non-US 0.0% 1 +19900.0%
Holding company 0.0% 1 +25.0%
Unknown 86.4% 10 +52.9%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

27 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
3.70% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
1
median weight 0.001%
Mar 31, 2026: 0
Crowding
2.57%
of shares outstanding, 10th percentile
Mar 31, 2026: 3.74%
Private-fund advisers
2.14%
of shares outstanding
Institutional ownership
21.8%
22.6% of the estimated free float
Top 10 holders
96.5%
of 13F shares, Herfindahl 0.359
Active holders
+38.9%
like-for-like share change of active filers
5% stakes on record
2
0 13D, 2 13G (0 institutional, 1 passive, 1 exempt)
How long holders have held it value-weighted 16.2 quarters
Under 1 year 34.0% 1 to 3 years 4.19% 3 years or more 61.8% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$1.36
estimated per share
Mar 31, 2026: $1.73
Quarter-end price
$1.77
implied by 13F values
Estimated gain or loss
+30.3%
price against the estimated cost
Estimated at a loss
9.23%
of costed 13F value

Estimated cost covers 43.2% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ENTX's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 LRMR Larimar Therapeutics, Inc. 3
2 FDMT 4D Molecular Therapeutics, Inc. 3
3 STOK Stoke Therapeutics, Inc. 3
4 ANNX Annexon, Inc. 3
5 IVA Inventiva S.A. 3
6 GLUE Monte Rosa Therapeutics, Inc. 3
7 ABSI Absci Corp 3
8 AVTX Avalo Therapeutics, Inc. 3
9 GPCR Structure Therapeutics Inc. 3
10 COGT Cogent Biosciences, Inc. 3

Shareholder Targets

13F filers that own its peers but not ENTX, quarter ended Jun 30, 2026

Found through its holder-overlap peers: LRMR, FDMT, STOK, ANNX, IVA, GLUE, ABSI, AVTX, GPCR, COGT, ABVX, RVMD. 1,008 filers in all.

# Filer In peers
1 FMR LLC Holding company, Diversified active $4,427,298,944 12 held
2 BlackRock, Inc. Holding company, Index-like $4,075,217,154 11 held
3 Jupiter Topco LLC Unknown, Diversified active $2,963,492,502 8 held
4 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $2,600,871,734 4 held
5 Darwin Global Management, Ltd. Exempt adviser, Concentrated $2,473,365,214 2 held
6 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $2,469,245,631 6 held
7 VANGUARD CAPITAL MANAGEMENT LLC Registered adviser, Index-like $2,345,248,480 9 held
8 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $1,949,181,704 9 held
9 STATE STREET CORP Bank, Index-like $1,619,692,961 11 held
10 Nextech Invest, Ltd. Exempt adviser, Concentrated $1,441,951,475 2 held
Showing 28 of 28
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1638097 CUSIP M40527109 13F (30d) 1 filings 1 filers Visit website Investor relations